Literature DB >> 12958261

Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis.

Kaisu Rantakokko-Jalava1, Sanna Laaksonen, Jouni Issakainen, Jukka Vauras, Jukka Nikoskelainen, Matti K Viljanen, Juha Salonen.   

Abstract

A real-time PCR method was developed and used to detect Aspergillus fumigatus mitochondrial DNA (mtDNA) in bronchoalveolar lavage (BAL) fluids and tissue biopsy specimens. The analytical sensitivity of the assay was one A. fumigatus conidium per reaction, and the assay was linear at least over 4 orders of magnitude above the detection limit. BAL fluids from 66 immunocompromised patients at risk of invasive pulmonary aspergillosis (IPA) and 33 immunocompetent controls and tissue biopsy specimens from 10 immunocompromised patients were analyzed. The results were related to the clinical diagnosis established according to recently published consensus criteria. A. fumigatus mtDNA positivity was encountered in 16 of 81 (20%) BAL fluid specimens from patients at risk and 1 of 33 (3%) specimens from immunocompetent controls. PCRs were positive in six of seven, two of four, and four of five of the patients with proven, probable, and possible IPA, respectively, as well as in four patients at risk but without any other evidence of IPA. With qualitative detection, the diagnostic sensitivity of PCR was 73%, specificity was 93%, and predictive values of positive (PPV) and negative (NPV) results were 73 and 95%, respectively. Using a threshold cycle of <35 as a limit for positive PCR, the specificity and PPV of PCR in the diagnosis of invasive aspergillosis were 100%, but its sensitivity was only 45% and NPV was 92%. PCR was positive in tissue biopsy specimens from all patients with invasive aspergillosis caused by A. fumigatus. Semiquantitative detection of A. fumigatus mtDNA in BAL fluid may be helpful in the diagnosis of IPA. PCR is well suited for the verification of the presence of A. fumigatus in tissue biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958261      PMCID: PMC193834          DOI: 10.1128/JCM.41.9.4304-4311.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

Authors:  J Maertens; J Verhaegen; K Lagrou; J Van Eldere; M Boogaerts
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

2.  Panfungal PCR and multiplex liquid hybridization for detection of fungi in tissue specimens.

Authors:  P H Hendolin; L Paulin; P Koukila-Kähkölä; V J Anttila; H Malmberg; M Richardson; J Ylikoski
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies.

Authors:  C Lass-Flörl; J Aigner; E Gunsilius; A Petzer; D Nachbaur; G Gastl; H Einsele; J Löffler; M P Dierich; R Würzner
Journal:  Br J Haematol       Date:  2001-04       Impact factor: 6.998

4.  Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome.

Authors:  J Salonen; O P Lehtonen; M R Teräsjärvi; J Nikoskelainen
Journal:  Scand J Infect Dis       Date:  2000

5.  Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid.

Authors:  M P Hayette; D Vaira; F Susin; P Boland; G Christiaens; P Melin; P De Mol
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 6.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR.

Authors:  H Skladny; D Buchheidt; C Baust; F Krieg-Schneider; W Seifarth; C Leib-Mösch; R Hehlmann
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Comparison between plasma and whole blood specimens for detection of Aspergillus DNA by PCR.

Authors:  J Loeffler; H Hebart; U Brauchle; U Schumacher; H Einsele
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

9.  Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.

Authors:  H Hebart; J Löffler; H Reitze; A Engel; U Schumacher; T Klingebiel; P Bader; A Böhme; H Martin; D Bunjes; W V Kern; L Kanz; H Einsele
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

10.  Nucleic acid sequence-based amplification of Aspergillus RNA in blood samples.

Authors:  J Loeffler; H Hebart; P Cox; N Flues; U Schumacher; H Einsele
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

View more
  20 in total

1.  Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.

Authors:  Masahito Kawazu; Yoshinobu Kanda; Yasuhito Nannya; Katsunori Aoki; Mineo Kurokawa; Shigeru Chiba; Toru Motokura; Hisamaru Hirai; Seishi Ogawa
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Biopsy procedures for molecular tissue diagnosis of invasive fungal infections.

Authors:  Cornelia Mrazek; Cornelia Lass-Flörl
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 3.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens.

Authors:  Claudia Schabereiter-Gurtner; Brigitte Selitsch; Manfred L Rotter; Alexander M Hirschl; Birgit Willinger
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

Review 5.  Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.

Authors:  Tomer Avni; Itzhak Levy; Hannah Sprecher; Dafna Yahav; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

Review 6.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.

Authors:  R Bialek; F Konrad; J Kern; C Aepinus; L Cecenas; G M Gonzalez; G Just-Nübling; B Willinger; E Presterl; C Lass-Flörl; V Rickerts
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

8.  Use of mycological, nested PCR, and real-time PCR methods on BAL fluids for detection of Aspergillus fumigatus and A. flavus in solid organ transplant recipients.

Authors:  Hossein Zarrinfar; Hossein Mirhendi; Koichi Makimura; Kazuo Satoh; Hossein Khodadadi; Omolbanin Paknejad
Journal:  Mycopathologia       Date:  2013-09-18       Impact factor: 2.574

Review 9.  PCR-based diagnosis of human fungal infections.

Authors:  Prasanna D Khot; David N Fredricks
Journal:  Expert Rev Anti Infect Ther       Date:  2009-12       Impact factor: 5.091

10.  Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance.

Authors:  E Fréalle; K Decrucq; F Botterel; B Bouchindhomme; D Camus; E Dei-Cas; J M Costa; I Yakoub-Agha; S Bretagne; L Delhaes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.